Advanced NanoTherapies Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $31M

  • Investors
  • 7

Advanced NanoTherapies General Information

Description

Developer of a biodegradable functionalized nanoparticle technology designed for cardiovascular and endovascular applications. The company creates technologies focusing on cardiovascular and endovascular applications that improve drug uptake and retention into the cell for medical devices, enabling clinicians to offer a safer therapeutic option to peripheral artery disease patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2903 Bunker Hill Lane
  • Suite 150
  • Santa Clara, CA 95054
  • United States
+1 (415)
Primary Industry
Drug Delivery
Other Industries
Therapeutic Devices
Other Healthcare Technology Systems
Corporate Office
  • 2903 Bunker Hill Lane
  • Suite 150
  • Santa Clara, CA 95054
  • United States
+1 (415)

Advanced NanoTherapies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Advanced NanoTherapies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 02-Jan-2026 $31M Completed Generating Revenue
2. Later Stage VC (Series A) 22-Aug-2023 Completed Generating Revenue
1. Seed Round 13-Oct-2020 $5.3M $5.3M Completed Generating Revenue
To view Advanced NanoTherapies’s complete valuation and funding history, request access »

Advanced NanoTherapies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-3
Series A-2
Series A-1 5,357,250 $0.000020 $1.49 $1.49 1x $1.49 26.67%
Seed 4,371,500 $0.000020 $1.12 $1.12 1x $1.12 21.76%
To view Advanced NanoTherapies’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Advanced NanoTherapies Patents

Advanced NanoTherapies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4469128-A1 Profiled drug-coated balloons using nanoparticles and methods of drug delivery therewith Pending 28-Jan-2022
EP-4469128-A4 Profiled drug-coated balloons using nanoparticles and methods of drug delivery therewith Pending 28-Jan-2022
GB-2630714-A Profiled drug-coated balloons using nanoparticles and methods of drug delivery therewith Pending 28-Jan-2022
US-20250114577-A1 Profiled drug-coated balloons using nanoparticles and methods of drug delivery therewith Pending 28-Jan-2022
WO-2023147102-A1 Profiled drug-coated balloons using nanoparticles and methods of drug delivery therewith Inactive 28-Jan-2022 A61M25/10184
To view Advanced NanoTherapies’s complete patent history, request access »

Advanced NanoTherapies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Advanced NanoTherapies Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
S3 Ventures Venture Capital Minority
BE Capital Corporation Minority
Kinled Holding Family Office Minority
T45 Labs Accelerator/Incubator Minority
TK & Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Advanced NanoTherapies FAQs

  • When was Advanced NanoTherapies founded?

    Advanced NanoTherapies was founded in 2018.

  • Where is Advanced NanoTherapies headquartered?

    Advanced NanoTherapies is headquartered in Santa Clara, CA.

  • What is the size of Advanced NanoTherapies?

    Advanced NanoTherapies has 10 total employees.

  • What industry is Advanced NanoTherapies in?

    Advanced NanoTherapies’s primary industry is Drug Delivery.

  • Is Advanced NanoTherapies a private or public company?

    Advanced NanoTherapies is a Private company.

  • What is Advanced NanoTherapies’s current revenue?

    The current revenue for Advanced NanoTherapies is .

  • How much funding has Advanced NanoTherapies raised over time?

    Advanced NanoTherapies has raised $50.2M.

  • Who are Advanced NanoTherapies’s investors?

    S3 Ventures, BE Capital, Kinled Holding, T45 Labs, and TK & Partners are 5 of 7 investors who have invested in Advanced NanoTherapies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process